Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Sara Lobo

Sara Lobo

Hospital Universitário de Santa Maria, Portugal

Title: Regression of large infantile multifocal hepatic hemangioma after Propranolol

Biography

Biography: Sara Lobo

Abstract

Recent literature describes several cases of successful response of infantile liver hemangioma to propranolol treatment. Some multifocal hepatic hemangioma can involve a massive area of the liver in children and carry a high risk of development of cardiovascular compromise, requiring a fast approach and monitoring. This case report describes a 3-months infant with a very large multifocal hepatic hemangioma for whom was proposed to start propranolol. Treatment was completed in a 20 months period with no report to side effects and a surprisingly fast response. The authors present this case to highlight the efficacy and safety of blocker-β propranolol treatment in young children even for very large liver hemangiomas.